Recombinant Human Serum Albumin-Interferon-Alpha-2b Fusion Protein (Shanxi Kangbao Biological Products/Institute of Biotechnology the Academy of Military Medical Sciences PLA)

N/A

Report date: 2025/01/26 17:37:31

Base Information

Drug NameRecombinant Human Serum Albumin-Interferon-Alpha-2b Fusion Protein (Shanxi Kangbao Biological Products/Institute of Biotechnology the Academy of Military Medical Sciences PLA)
Drug Alias NamerHSA-IFN Alpha-2b (Shanxi Kangbao Biological Products/Institute of Biotechnology the Academy of Military Medical Sciences PLA)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionSerum albumin modulatorsInterferon alpha 2 ligand
TargetsSerum albuminInterferon alpha-2
Therapy Area/IndicationsHepatitisNeoplasmsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Biotechnology, Academy Of Military Medical Sciences. Pla Of China
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Biotechnology, Academy Of Military Medical Sciences. Pla Of ChinaShanxi Kangbao Biological Product Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasmsHepatitis B
Inactive IndicationsHepatitis

Other Information

ATC CodeN/A
Related LinksN/A